Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A.

Antiviral Res. 2016 Aug;132:178-85. doi: 10.1016/j.antiviral.2016.06.001. Epub 2016 Jun 3.

2.

Reverse genetics vaccine seeds for influenza: Proof of concept in the source of PB1 as a determinant factor in virus growth and antigen yield.

Gíria M, Santos L, Louro J, Rebelo de Andrade H.

Virology. 2016 Sep;496:21-7. doi: 10.1016/j.virol.2016.05.015. Epub 2016 May 27.

PMID:
27240145
3.

Future directions for the European influenza reference laboratory network in influenza surveillance.

Goddard N, Rebelo-de-Andrade H, Meijer A, McCauley J, Daniels R, Zambon M.

Euro Surveill. 2015 Jul 30;20(30). pii: 21195.

4.

Distinct kinetics and pathways of apoptosis in influenza A and B virus infection.

Santos LA, Solá S, Rodrigues CM, Rebelo-de-Andrade H.

Virus Res. 2015 Jul 2;205:33-40. doi: 10.1016/j.virusres.2015.05.008. Epub 2015 May 19.

PMID:
26002021
5.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M.

Antiviral Res. 2015 May;117:27-38. doi: 10.1016/j.antiviral.2015.02.003. Epub 2015 Feb 23.

6.

Genetic evolution of PB1 in the zoonotic transmission of influenza A(H1) virus.

Gíria M, Rebelo de Andrade H.

Infect Genet Evol. 2014 Oct;27:234-43. doi: 10.1016/j.meegid.2014.07.024. Epub 2014 Aug 1.

PMID:
25092558
7.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC.

Antiviral Res. 2014 Oct;110:31-41. doi: 10.1016/j.antiviral.2014.07.001. Epub 2014 Jul 17.

8.

Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.

Correia V, Santos LA, Gíria M, Almeida-Santos MM, Rebelo-de-Andrade H.

J Med Virol. 2015 Jan;87(1):45-56. doi: 10.1002/jmv.23986. Epub 2014 Jul 21.

PMID:
25042157
9.

I-MOVE: a European network to measure the effectiveness of influenza vaccines.

Valenciano M, Ciancio B; I-MOVE study team..

Euro Surveill. 2012 Sep 27;17(39). pii: 20281.

10.

Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.

Gíria MT, Rebelo de Andrade H, Santos LA, Correia VM, Pedro SV, Santos MA.

J Clin Virol. 2012 Feb;53(2):140-4. doi: 10.1016/j.jcv.2011.11.002. Epub 2011 Dec 15.

PMID:
22177272
11.

Antibody response to the influenza vaccine in healthcare workers.

Sacadura-Leite E, Sousa-Uva A, Rebelo-de-Andrade H.

Vaccine. 2012 Jan 5;30(2):436-41. doi: 10.1016/j.vaccine.2011.10.061. Epub 2011 Nov 4.

PMID:
22064268
12.

Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004.

Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Nogueira P, Miller M.

PLoS One. 2011;6(6):e20661. doi: 10.1371/journal.pone.0020661. Epub 2011 Jun 21.

13.

Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain.

Rebelo-de-Andrade H, Pereira C, Gíria M, Prudêncio E, Brito MJ, Calé E, Taveira N.

J Clin Microbiol. 2010 Apr;48(4):1391-6. doi: 10.1128/JCM.02019-09. Epub 2010 Feb 10.

14.

Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008.

Meerhoff TJ, Mosnier A, Schellevis F, Paget WJ; EISS RSV Task Group..

Euro Surveill. 2009 Oct 8;14(40). pii: 19346.

15.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme..

Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.

16.

Report on the measles situation in Portugal.

Gíria M, Rebelo-de-Andrade H, Fernandes T, Pedro S, Freitas G.

Euro Surveill. 2008 Oct 16;13(42). pii: 19010. No abstract available.

17.

Heterogeneous selective pressure acting on influenza B Victoria- and Yamagata-like hemagglutinins.

Nunes B, Pechirra P, Coelho A, Ribeiro C, Arraiolos A, Rebelo-de-Andrade H.

J Mol Evol. 2008 Oct;67(4):427-35. doi: 10.1007/s00239-008-9154-9. Epub 2008 Oct 8.

PMID:
18841406
18.

Characterization of influenza A/Fujian/411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005.

Pechirra P, Gonçalves P, Arraiolos A, Coelho A, Rebelo-de-Andrade H.

J Med Virol. 2008 Sep;80(9):1624-30. doi: 10.1002/jmv.21258.

PMID:
18649331
19.

Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe.

van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenço JM, Gomes MG.

Euro Surveill. 2007 Jul 1;12(7):E5-6.

PMID:
17991409
20.

Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002.

Pires de Miranda M, Carmo Gomes M, Rebelo de Andrade H.

Euro Surveill. 2007 Jun 1;12(6):E7-8. Erratum in: Euro Surveill. 2007 Sep;12(9):E070913.4.

PMID:
17991403

Supplemental Content

Loading ...
Support Center